
Holly Large is a PhD student at the University of Leicester, with interests in public health genomics and science communication. Before joining the University of Leicester she worked as Technology Networks' editorial assistant. In her role as editorial assistant Holly supported the publication’s in-house writers.
Got a Question for Holly Large?
Get in touch using the contact form linked here and we’ll get back to you shortly.

Rapid COVID-19 Vaccine Development Enabled by Previous Research Investments, Study Suggests

Rare Blood Clotting Disorder Risk Higher Following COVID-19 Than Post-Vaccination

UK Government-Funded COVID-19 Vaccine Phase I/II Trials Report Positive Data

New Survey Highlights Public Support for Donation of COVID-19 Vaccines to Low-Income Countries

New Data Suggests UK’s COVID-19 Vaccination Program Has Prevented Thousands of Elderly Deaths

Existing Vaccines May Protect Against New SARS-CoV-2 Variants

New Vaccine Development Partnerships Established To Tackle SARS-CoV-2 Variants

Single Dose of Pfizer or Oxford Vaccine May Significantly Reduce Risk of Elderly COVID-19 Hospitalizations

Supporting the Next Generation of Scientists
